Effect of danazol on serum concentrations of pituitary gonadotropins in postmenopausal women
article
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This study found that danazol treatment in postmenopausal women significantly decreased serum FSH and LH concentrations after four weeks, irrespective of dose.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The antigonadotropic action of danazol is still a subject of controversy. Danazol does not cause a consistent and significant suppression of basal gonadotropin concentrations in premenopausal women. In order to investigate the possible effects of danazol on circulating gonadotropin levels in the absence of gonadal feedback, postmenopausal women were studied. Twelve healthy women, at least 3 years past the menopause, volunteered. Their mean age was 61.1 +/- 5.5 (SD) years. Danazol in daily doses of 400, 600 or 800 mg was given randomized, to 4 patients each, for 4 weeks. Venous samples were drawn at -1, 0, +1, +2, +4 weeks of medication. FSH and LH in serum were measured by means of double antibody radio-immunoassay. There was no significant difference between any of the pre-treatment means in the three dose groups. After 4 weeks of danazol treatment, FSH had decreased by 18%, 31%, and 32% in the 400, 600 and 800 mg groups, respectively. The corresponding decreases in LH were 14%, 24% and 21%. There was no significant dose response between any of the doses used. In the absence of significant differences between the pre-treatment means and of significant dose response, data for all 12 patients were pooled for statistical evaluation. The mean decrease in FSH was significant only after 4 weeks (-4.8 micrograms/l; p less than 0.001). The mean decrease in LH was significant after 1, 2 and 4 weeks of treatment (-1.0 to -1.13; p less than 0.01 or less).(ABSTRACT TRUNCATED AT 250 WORDS)
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (13)
- Clinical Studies with an Antigonadotropin-Danazol via openalex
- Danazol—a Synthetic Steroid Derivative with Interesting Physiologic Properties via openalex
- Effects of Danazol on Pituitary Gonadotrophins in Post‐Menopausal Women via openalex
- Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women via openalex
- Endocrine effects of danazol in menstruating women. via openalex
- Hormonal changes associated with Danazol therapy. via openalex
- Pituitary Gonadotropin Inhibitory Activity of Danazol via openalex
- The Effect of Danazol on Anterior Pituitary Function via openalex
- The effects of danazol on gonadotropins and steroid blood levels in normal and anovulatory women. via openalex
- doi:10.1016/s0015-0282(16)43869-0 via openalex
- doi:10.1677/joe.0.0700335 via openalex
- doi:10.1530/acta.0.0710716 via openalex
- doi:10.1210/jcem-34-4-671 via openalex
Cited by (3)
Source provenance
- openalex
- last seen: 2026-05-14T05:56:02.807635+00:00
- unpaywall
- last seen: 2026-08-24T06:27:14.670421+00:00
License: CC0
· commercial use OK